Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Delonix Bioworks is a Shanghai-based startup using synthetic biology to design bacteria to act as safer and more effective vaccines against bacterial infections and cancer. The Delonix team has developed a novel approach that builds on the established concept of live attenuated bacteria and combines it with the latest developments in synthetic biology. Delonix’s synthetic […]
Orna Therapeutics is an MIT spin-off developing fully engineered circular RNA (oRNA) therapeutics, a new class of RNA medicines with the potential to treat a wide range of diseases including cancer, autoimmune, and genetic disorders. Built on research from Prof. Daniel Anderson’s lab at MIT, oRNA is described by the company as the next revolution […]
Baccuico has developed a proprietary bacterial cultivation platform that combines directed evolution, next generation sequencing, and machine learning to access novel compounds from biological ‘dark matter’. The company’s Bacterial Community Cultivation platform (BACCU) directs the evolution of unculturable bacteria, so that the bacteria evolve to become culturable in the lab. Once brought into the laboratory, […]